Melanoma genomics – will we go beyond BRAF in clinics?
Abstract In the era of next-generation sequencing, the genetic background of cancer, including melanoma, appears to be thoroughly established. However, evaluating the oncogene BRAF mutation in codon V600 is still the only companion diagnostic genomic test commonly implemented in clinics for molecula...
Saved in:
| Main Authors: | Justyna Mirek, Wiesław Bal, Magdalena Olbryt |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-09-01
|
| Series: | Journal of Cancer Research and Clinical Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s00432-024-05957-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Melanoma genomics– will we go beyond BRAF in clinics?
by: Justyna Mirek, et al.
Published: (2025-02-01) -
Systemic therapy of skin metastatic melanoma with BRAF gene mutation
by: Yu. S. Shakh-Paronyants, et al.
Published: (2023-03-01) -
High BRAF V600 Mutation Level Associated with Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors
by: Ariane Fizazi, et al.
Published: (2024-11-01) -
Resistance to BRAF inhibitors drives melanoma sensitivity to Chk1 inhibition
by: Danielle G. Carvalho, et al.
Published: (2025-07-01) -
The combination of mutations in BRAF and NRAS genes within a one tumor in patients with cutaneous melanoma
by: M. B. Aksenenko, et al.
Published: (2019-10-01)